Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine

Journal of Neurochemistry

Volumn 94, Issue 5, 2005, Pages 1402-1410

  Owens, W Anthony ^a   Sevak, Rajkumar J ^a   Galici, Ruggero ^a   Chang, Xiaoying ^a   Javors, Martin A ^a   Galli, Aurelio ^b   France, Charles P ^a   Daws, Lynette C ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Chronoamperometry; Dopamine transporter; Insulin; Locomotor activity; Striatum

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; GLUCOSE; INSULIN; STREPTOZOCIN; TRITIUM;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG SELF ADMINISTRATION; GLUCOSE BLOOD LEVEL; HYPOINSULINEMIA; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SYNAPTOSOME;

AMPHETAMINE; ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG ADMINISTRATION SCHEDULE; INSULIN; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 24144454799     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03289.x     Document Type: Article

References (41)

1. Barber M., Kasturi B. S., Austin M. E., Patel K. P., MohanKuman S. M. and MohanKuman P. S. (2003) Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res. 964, 128-135.
2. Carr K. D., Kim G.-Y. and Cabeza de Vaca S. (2000) Hypoinsulinemia may mediate the lowering of self-administration thresholds by food restriction and streptozotocin-induced diabetes. Brain Res. 863, 160-168.
3. Carroll M. E. and Stotz D. C. (1983) Oral d-amphetamine and ketamine self-administration by rhesus monkeys: effects of food deprivation. J. Pharmacol. Exp. Ther. 227, 28-34.
4. Carvelli L., Morón J. A., Kahlig K. M. et al. (2002) PI 3-kinase regulation of doparnine uptake. J. Neurochem. 81, 859-869.
5. Cass W. A. and Gerhardt G. A. (1994) Direct in vivo evidence that D2 dopamine receptors can modulate doparnine uptake. Neurosci. Lett. 176, 259-263.
6. Chan O., Inouye K., Akirav E., Park E., Riddell M. C., Vranic M. and Matthews S. G. (2005) Insulin alone increases hypothalamo-pituitary-adrenal activity, and diabetes lowers peak stress responses. Endocrinology 146, 1382-1390.
7. Cheatham B. and Kahn C. R. (1995) Insulin action and the insulin signaling network. Endocrine Rev. 16, 117-142.
8. Chen H., Brahmbhatt S., Gupta A. and Sharma A. C. (2005) Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction. Cardiovascular Diabetol. 4:3, doi: 10.1186/1475-2840-4-3.
9. Cheta D. (1998) Animal models of type I (insulin-dependent) diabetes mellitus. J. Pediatr. Endocrinol. Metab. 11, 11-19.
10. Cragg S. J. and Rice M. E. (2004) DAncing past the DAT at a DA synapse. Trends Neurosci. 21, 270-277.
11. Daws L. C., Irvine R. J., Callaghan P. D., Toop N. P., White J. M. and Bochner F. (2000) Differential behavioral and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in rat. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 24, 955-977.
12. Dickinson S. D., Sabeti J., Larson G. A. et al (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neumchem. 72, 148-156.
13. Figlewicz D. P. (2003) Insulin, food intake and reward. Semin. Clin. Neuropsychiatry 8, 82-93.
14. Fleckenstein A. E., Metzger R. R., Wilkins D. G., Gibb J. W. and Hanson G. R. (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282, 834-838.
15. Galici R., Galli A., Jones D. J., Sanchez T. A., Saunders C. A., Frazer A., Gould G. G., Lin R. Z. and France C. P. (2003) Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 77, 132-140.
16. Garcia B., Wei Y., Moron J. A., Lin R. Z., Javitch J. A. and Galli A. (2005) AKT is essential for insulin modulation of amphetamine-induced human dopamine transporter cell surface redistribution. Mol. Pharmacol. doi: 10.1124/mol.l04.009092.
17. Grigson P. S. (2002) Like drugs for chocolate: separate rewards modulated by common mechanisms? Physiol. Behav. 76, 389-395.
18. Hebert M. and Gerhardt G. A. (1999) Age-related changes in the capacity, rate and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 244 rats: An in vivo electrochemical study. J. Pharmacol. Exp. Ther. 288, 879-887.
19. Kamei J. and Ohsawa M. (1996) Effects of diabetes on methamphetamine- induced place preference in mice. Eur. J. Pharmacol. 318, 251-256.
20. Kuczenski R. and Segal D. S. (1988) Psychomotor stimulant-induced sensitization: behavioral and neurochemical correlates, in Sensitization in the Nervous System (Kalivas, P. W. and Barnes, C. D., eds), pp. 175-205. Caldwell, Telford, NJ.
21. Lim D. K., Lee K. M. and Ho I. K. (1994) Changes in the central dopaminergic systems in the streptozotocin-induced diabetic rats. Arch. Pharm. Res. 17, 398-404.
22. Marshall J. F. (1978) Further analysis of the resistance of the diabetic rat to d-amphetamine. Pharmacol. Biochem. Behav. 8, 281-286.
23. Meiergerd S. M., Patterson T. A. and Schenk J. O. (1993) D2 receptors may modulate the function of the striatal transporter for DA: Kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764-767.
24. Merali Z., Ahmad Q. and Veitch J. (1988) Behavioral and neurochemical profile of the spontaneously diabetic Wistar BB rat. Behav. Brain. Res. 29, 51-60.
25. Near J. A., Bigelow J. C. and Wightman R. M. (1988) Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J. Pharmacol. Exp. Ther. 245, 921-927.
26. Nitta A., Murai R., Suzuki N., Ito H., Nomoto H., Katoh G., Furukawa Y. and Furukawa S. (2002) Diabetic neuropathies in brain are induced by deficiency in of BDNF. Neurotoxicol. Teratol. 24, 695-701.
27. Page G., Bare-Pain S., Pontcharraud R., Cante A., Piriou A. and Barrier L. (2004) The up-regulation of the striatal dopamine transporter's activity by cAMP is PKA-, CaMK II- and phosphatase-dependent. Neurochem. Int. 45, 627-632.
28. Patterson T, A., Brot M. D., Zavosh A., Schenk J. O., Szot P. and Figlewicz D. P. (1998) Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68, 11-20.
29. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, New York.
30. Reagan L. P., Magarinos A. and McEwen B. S. (1999) Neurological changes induced by stress in streptozotocin diabetic rats. Ann. N.Y. Acad. Sci. 893, 126-137.
31. Schultz W. (2001) Reward signaling by dopamine neurons. Neuroscientist 7, 293-302.
32. Seeman P., Tallerico T., Ko F., Term C. and Kapur S. (2002) Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenge. Synapse 46, 235-239.
33. Shimomura Y., Shimizu H., Takahashi M., Uehara Y., Kobayashi I. and Kobayashi S. (1990) Ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats. Exp. Clin. Endocrinol. 95, 385-388.
34. Sipols A. J., Stuber G. D., Klein S. N., Higgins M. S. and Figlewicz D. P. (2000) Insulin and raclopride combine to decrease short-term intake of sucrose solutions. Peptides 21, 1361-1367.
35. Sumiyoshi T, Ichikawa J. and Meltzer H. Y. (1997) The effect of streptozotocin-induced diabetes on dopamine D2, serotonin1A and serotonin2A receptors in the rat brain. Neumpsychopharmacology 16, 183-190.
36. Szkudelski T. (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50, 536-546.
37. Torres G. E., Gainetdinov R. R. and Caron M. G. (2003) Plasma membrane monoamine transporters: Structure, regulation and function. Nat. Rev. Neurosci. 4, 13-25.
38. Vaughan R. (2004) Phosphorylation and regulation of psychostimulant- sensitive neurotransmitter transporters. J. Pharmacol. Exp. Ther. 310, 1-7.
39. Wolfe W. L. and Maisto S. A. (2000) The relationship between eating disorders and substance abuse: Moving beyond co-prevalence research. Clin. Psychol. Rev. 20, 617-631.
40. -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 21-55.
41. Zahniser N. R., Larson G. A. and Gerhardt G. A. (1999) In vivo dopamine clearance rate in rat striatum: Regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J. Pharmacol. Exp. Ther. 289, 266-277.